A. T. Santomauro

[Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].

R. Souto, A. C. Santomauro Júnior, M. Ugolini, 2008, Arquivos brasileiros de endocrinologia e metabologia.

Insulin resistance in limb and trunk partial lipodystrophy (type 2 Köbberling-Dunnigan syndrome).

D. M. Rocha, B. Wajchenberg, M. S. Galvão, 1997, Metabolism: clinical and experimental.

Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.

D. M. Rocha, G. Boden, B. Wajchenberg, 1999, Diabetes.

Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence.

B. Wajchenberg, A. T. Santomauro, D. Malerbi, 1994, Diabetes/metabolism reviews.

A case of congenital generalized lipodystrophy: metabolic effects of four dietary regimens. Lack of association of CGL with polymorphism in the lamin A/C Gene

K. Silver, C. Yen, A. Shuldiner, 2001, Clinical endocrinology.

Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons

R. Maranhão, B. Wajchenberg, R. F. Amâncio, 2004, Clinical endocrinology.

Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.

D. Giannella‐Neto, B. Wajchenberg, A. T. Santomauro, 1992, Diabetes research and clinical practice.

Risk factors in obese women, with particular reference to visceral fat component.

B. Wajchenberg, A. Bosco, A. T. Santomauro, 1997, Diabetes & metabolism.

Effect of a sulfonylurea (gliclazide) treatment on insulin sensitivity and glucose-mediated glucose disposal in patients with non-insulin-dependent diabetes mellitus (NIDDM).

B. Wajchenberg, A. T. Santomauro, R. Porrelli, 1993, Diabetes Research and Clinical Practice.